Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro

Journal of Infectious Diseases

Volumn 186, Issue 8, 2002, Pages 1161-1164

  Lin, Tzou Yien ^a   Chu, Chishih ^b   Chiu, Cheng Hsun ^a  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENTEROVIRUS; EPIDEMIC; HUMAN; HUMAN CELL; IC 50; NEUROLOGIC DISEASE; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS INFECTION; VIRUS INHIBITION;

ANTIVIRAL AGENTS; ENTEROVIRUS; HUMANS; INHIBITORY CONCENTRATION 50; LACTOFERRIN; PLAQUE ASSAY; RHABDOMYOSARCOMA, EMBRYONAL; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0037108680     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/343809     Document Type: Article

References (17)

1. Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, von Ziepel G. New enterovirus type associated with epidemic of aseptic meningitis and/or hand, foot, and mouth disease. Lancet 1974;2:112.
2. Chumakov M, Voroshilova M, Shindarov L, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 1979;60:329-40.
3. Gilbert GL, Dickson KE, Waters MJ, Kennett ML, Land SA, Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J 1988;7:484-8.
4. Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol 1982;71:217-27.
5. Samuda GM, Chang WK, Yeung CY, Tang PS. Monoplegia caused by enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J 1987;6: 206-8.
6. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 1999;341:929-35.
7. Chang LY, Lin TY, Huang YC. Fulminant neurogenic pulmonary edema with hand, foot, and mouth disease. Lancet 1998;352:367-8.
8. Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J 1999;18:1033-40.
9. Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1977;197:263-5.
10. Harmsen MC, Swart PJ, de Bethune MP, et al. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 1995;172:380-8.
11. Marchetti M, Longhi C, Conte MP, Pisani S, Valenti P, Seganti L. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res 1996;29:221-31.
12. van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK. Antiviral activities of lactoferrin. Antiviral Res 2001;52:225-39.
13. Weinberg ED. Human lactoferrin: a novel therapeutic with broad spectrum potential. J Pharm Pharmacol 2001;53:1303-10.
14. Zou S, Magura CE, Hurley WL. Heparin-binding properties of lactoferrin and lysozyme. Comp Biochem Physiol B 1992;103:889-95.
15. Mets-Boutigue MH, Jolles J, Mazurier J, et al. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem 1984;145:659-76.
16. Pierce A, Colavizza D, Benaissa M, et al. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur J Biochem 1991;196:177-84.
17. Yamauchi K, Giehl TJ, Ellison RT. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993;61: 719-28.